Clinical Trial

Oriental Research AlliaNce of Acute Ischemic Stroke Given Endovascular Treatment

Study acronym: ORANGE
Recruiting
View on ClinicalTrials.gov →
Summary
To determine the safety and efficacy of in situ ischemic postconditioning immediately after successful reperfusion in AIS patients underwnet EVT.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2021-08-22; most recent amendment 2023-07-10.
Status change: Enrolling by Invitation → Recruiting 2023-05-01
Trial Details
NCT Number NCT05024292
Lead Sponsor Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Collaborators: Zhangzhou Municipal Hospital of Fujian Province
Conditions Ischemic Stroke
Enrollment 160 participants
Start Date 2022-01-01
Primary Completion 2026-12 (estimated)
Study Completion 2027-04 (estimated)
Updated on ClinicalTrials.gov 2023-07-12